Mark E. Saad

Insider Reports History

Entity
Individual
Location
C/O Cytori Therapeutics, Inc., 3020 Callan Road, San Diego, California
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark E. Saad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Director Stock Option (Right to Buy) 5.8K Jun 7, 2024 Direct

Insider Reports Filed by Mark E. Saad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXSM Axsome Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
AXSM Axsome Therapeutics, Inc. Feb 27, 2024 1 $0 4 Feb 29, 2024 Director
AXSM Axsome Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Director
AXSM Axsome Therapeutics, Inc. Mar 2, 2023 1 $0 4 Mar 6, 2023 Director
AXSM Axsome Therapeutics, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director
AXSM Axsome Therapeutics, Inc. Mar 4, 2022 1 $0 4 Mar 8, 2022 Director
AXSM Axsome Therapeutics, Inc. Nov 17, 2021 4 $114K 4 Nov 19, 2021 Director
AXSM Axsome Therapeutics, Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director